ArticleBMC cancer2022

Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort.

Majd Issa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.